STEPHANIE HAIRE: Open Payments
NPI 1194001867 · WINTER SPRINGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,396 in 108 payments from 18 companies in 2025. Trend: 2023 $2,047 · 2024 $1,867 · 2025 $2,396
Food & beverage: $2,396
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 17 | $458 |
| ABBVIE INC. | 14 | $336 |
| Vanda Pharmaceuticals Inc. | 20 | $335 |
| Neurocrine BioSciences, Inc. | 8 | $283 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $258 |
| Corium, LLC | 10 | $231 |
| Janssen Pharmaceuticals, Inc | 5 | $114 |
| E.R. Squibb & Sons, L.L.C. | 4 | $86 |
| Axsome Therapeutics, Inc. | 2 | $61 |
| Supernus Pharmaceuticals, Inc. | 3 | $49 |
Products named: REXULTI, VRAYLAR, FANAPT, INGREZZA, CAPLYTA, Azstarys, ABILIFY ASIMTUFII, COBENFY.
Industry payments across FL — which companies pay providers there.
